Source - RNS
RNS Number : 4270L
Collagen Solutions PLC
03 October 2016


 3 October 2016


Collagen Solutions plc

("Collagen Solutions" or the "Company")


Change of Adviser


Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it has appointed Cenkos Securities plc as its Nominated Adviser and Broker with immediate effect.


About Collagen Solutions:

Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The capabilities of the Company include the provision of native, soluble and powdered collagen formulations, processed and semi-processed tissues such as pericardium, bone, and blood vessels, and expertise in the development and contract manufacture of collagen components for use as engineered tissue scaffolds and other medical devices. These products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology. Collagen Solutions' unique offering extends beyond material supply and contract services through the highly skilled staff who support customers through the various stages of development and regulatory approval. For additional information, please visit




Collagen Solutions plc

Tel: 0141 648 9100

Jamal Rushdy, Chief Executive Officer


Gill Black, Chief Financial Officer




Cenkos Securities plc (Nominated Adviser & Broker)

Tel: 0207 397 8900

Stephen Keys


Steve Cox




Walbrook PR Ltd (Financial PR & IR)

Tel: 020 7933 8780

Anna Dunphy


Mike Wort





This information is provided by RNS
The company news service from the London Stock Exchange